February 19, 2009 - When it comes to a heart attack, every second counts, and the Occluded Artery Trial (OAT) underscores how very important it is for individuals experiencing a heart attack to take their symptoms seriously, call 911, and undergo prompt treatment, says the Society for Cardiovascular Angiography and Interventions (SCAI).

February 19, 2009 - C. R. Bard Inc. this week said it received pre-market approval (PMA) from the FDA to market the LifeStent FlexStar and FlexStar XL Vascular Stent Systems, which are approved for the treatment of occlusive disease in native superficial femoral arteries (SFA) and proximal popliteal arteries.

February 19, 2009 - The New England Journal of Medicine this week published the results from the SYNTAX trial, in which percutaneous coronary intervention (PCI) using the TAXUS Express2 Paclitaxel-Eluting Coronary Stent was compared to contemporary coronary artery bypass graft (CABG) surgery in patients with the most complex coronary artery disease (CAD).

February 19, 2009 - Acusphere Inc. today submitted an amendment to its new drug application (NDA) for its ultrasound contrast agent Imagify (perflubutane polymer microspheres for injectable suspension), which is designed for the detection of coronary artery disease.

February 19, 2009 – Siemens Healthcare released the Symbia E single detector imaging system to its Symbia family of scanners. The Symbia E is designed to be a a high-quality, cost-effective single photon emission computed tomography (SPECT) system that can help improve clinical confidence, reliability and versatility.

February 19, 2009 - The Society of Chest Pain Centers will hold its 12th Congress of Chest Pain Centers event April 29-May 2, 2009 at the Peabody Hotel in Memphis, TN.

February 19, 2009 - Molecular diagnostic company TrimGen Corp. has received FDA 510(k) clearance to market its eQ-PCR LC Warfarin Genotyping kit, an assay used to aid identification of patients who may be at risk of warfarin sensitivity.

February 19, 2009 - The Society for Women's Health Research and the Medical Imaging & Technology Alliance (MITA) reminded women of the diagnostic technology available that can detect heart disease while it is treatable, and released a fact sheet to help patients and their families better understand the noninvasive diagnostic technologies that can be used to help detect coronary disease.


Frank Rybicki, M.D., director of cardiac CT and vascular CT, MRI, Brigham and Women’s Hospital, sat down with Imaging Technology News (ITN) to talk about the Toshiba-sponsored Core-320 trial that will compare coronary CT angiography with myocardial perfusion performed on Toshiba’s Acquilion ONE against traditional invasive angiography and SPECT. The trial is set to begin later this year.

February 18, 2009 - InSite One Inc. said today that the InDex Archive has reached a new milestone with over 31 million studies in this single object repository representing approximately 4.5 percent of the U.S. diagnostic imaging patient population in 2008.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now